GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Baijin Life Science Holdings Ltd (HKSE:01466) » Definitions » 5-Year EBITDA Growth Rate

Baijin Life Science Holdings (HKSE:01466) 5-Year EBITDA Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Baijin Life Science Holdings 5-Year EBITDA Growth Rate?

Baijin Life Science Holdings's EBITDA per Share for the six months ended in Sep. 2024 was HK$0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 62.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Baijin Life Science Holdings was 62.10% per year. The lowest was -121.10% per year. And the median was 36.30% per year.


Competitive Comparison of Baijin Life Science Holdings's 5-Year EBITDA Growth Rate

For the Luxury Goods subindustry, Baijin Life Science Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baijin Life Science Holdings's 5-Year EBITDA Growth Rate Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Baijin Life Science Holdings's 5-Year EBITDA Growth Rate falls into.


;
;

Baijin Life Science Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Baijin Life Science Holdings  (HKSE:01466) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Baijin Life Science Holdings 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Baijin Life Science Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Baijin Life Science Holdings Business Description

Traded in Other Exchanges
Address
66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.
Executives
Pacific Wish Limited
Chan Vincent Wing Sing
Hui Ka Man Emily
Ketto Inform Limited 2101 Beneficial owner
Su Yaoyao 2201 Interest of corporation controlled by you

Baijin Life Science Holdings Headlines

No Headlines